A less studied member of the TGFβ family, the ligand Activin A, has been shown to be upregulated in the progression from Barrett's esophagus to dysplasia and ultimately esophageal adenocarcinoma [17]. This evidence concerns the gene TGFB1 and esophageal adenocarcinoma.